Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization

Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization

Item
http://www.wikidata.org/entity/Q34522235
Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimatesComparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimatesEffects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative.Different thresholds for detecting osteophytes and joint space narrowing exist between the site investigators and the centralized reader in a multicenter knee osteoarthritis study--data from the Osteoarthritis InitiativeEffects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trialLessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on DialysisDetermination of the underlying cause of death in three multicenter international HIV clinical trials.Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeDo we need to adjudicate major clinical events?Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention.Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts.A comparison of approaches for adjudicating outcomes in clinical trials.First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial.Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs.Alignment of site versus adjudication committee-based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial.
P2860

Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization

Item
http://www.wikidata.org/entity/Q34522235
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Misreporting of myocardial inf ...... vents in a Global Organization
@ast
Misreporting of myocardial inf ...... vents in a Global Organization
@en
Misreporting of myocardial inf ...... vents in a Global Organization
@nl
type
label
Misreporting of myocardial inf ...... vents in a Global Organization
@ast
Misreporting of myocardial inf ...... vents in a Global Organization
@en
Misreporting of myocardial inf ...... vents in a Global Organization
@nl
prefLabel
Misreporting of myocardial inf ...... vents in a Global Organization
@ast
Misreporting of myocardial inf ...... vents in a Global Organization
@en
Misreporting of myocardial inf ...... vents in a Global Organization
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Misreporting of myocardial inf ...... vents in a Global Organization
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921